Advertisement

Topics

Gastroenterology Reports

02:13 EDT 24th March 2017 | BioPortfolio

Concordia International Corp CXR Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 23022017] Prices from USD $250

SummaryConcordia International Corp Concordia, formerly Concordia Healthcare Corp is a pharmaceutical company that offers orphan drugs. The company undertakes the management and acquisition of legacy pharmaceutical products, orphan drugs and medical devices for diabetics. Its product portfolio comprises Orapred, Donnatal, Ulesfia, Zonegran, Dibenzyline, Dutoprol, Dyrenium, Fortaz, Kayexalate, Lano...

Calypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 23022017] Prices from USD $250

SummaryCalypso Biotech SA Calypso, a spinoff from Merck Serono is a biopharmaceutical company that discovers, develops and commercializes antibody therapies. Its pipeline products include CALY0001, a therapeutic antibody used in the treatment of crohn's disease; and CALY0002 a humanized monoclonal antibody used in the treatment of refractory celiac disease. The company is also developing humanized...

Calypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10032017] Prices from USD $250

SummaryCalypso Biotech SA Calypso, a spinoff from Merck Serono is a biopharmaceutical company that discovers, develops and commercializes antibody therapies. Its pipeline products include CALY0001, a therapeutic antibody used in the treatment of crohn's disease; and CALY0002 a humanized monoclonal antibody used in the treatment of refractory celiac disease. The company is also developing humanized...

Cancer Research UK Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 23022017] Prices from USD $250

SummaryCancer Research UK CRUK is a research institution that offers clinical research services. The institute offers cancer research services for anal cancer, bile duct cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's cancer, choriocarcinoma, chronic lymphocytic leukaemia, chronic myeloid leukaemia, colon cancer, colorectal ca...

Immunotherapeutics Global Market Forecast To 2021 [Updated: 16112015] Prices from USD $4500

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy. The global immunotherapeutics market is divided based on the segments, application and geography. Based on the segments, the immu...

Guided Therapeutics Inc GTHP Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryGuided Therapeutics Inc GTI, formerly SpectRx, Inc. is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company offers products for the noninvasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect dis...

ImmusanT Inc Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryImmusanT Inc ImmusanT is a biotechnology company that discovers and develops therapies for celiac disease. The company's pipeline products portfolio includes Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT s pipeline products are also used for the treatment of diabetes, thyroid autoimmunity, autoimmune liver disea...

H. Lee Moffitt Cancer Center Research Institute Inc Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryH. Lee Moffitt Cancer Center Research Institute Inc Moffitt is a notforprofit cancer treatment and research institution that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional...

Muscle Invasive Bladder Cancer MIBC Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Muscle Invasive Bladder Cancer MIBC Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Muscle Invasive Bladder Cancer MIBC Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer MIBC clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer MIBC. Report inclu...

Cancer Pain Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Cancer Pain Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Cancer Pain Global Clinical Trials Review, H2, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across ...

Guided Therapeutics Inc GTHP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryGuided Therapeutics Inc GTI, formerly SpectRx, Inc. is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company offers products for the noninvasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect dis...

Fox Chase Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryFox Chase Cancer Center Fox Chase, formerly American Oncologic Hospital, Inc., a subsidiary of Temple University Health System, Inc., offers clinical care and research and training services. The center offers screening services for breast, colorectal, prostate, lung and skin cancers, and Barrett's Esophagus. It offers clinical care services for various conditions such as adrenal mass, bladd...

Helsinn Healthcare SA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryHelsinn Healthcare SA Helsinn Healthcare, a subsidiary of Helsinn Holding SA, which provides cancer care solutions. It offers products in various therapeutic areas that include pain and inflammation, cancer care and gastroenterology. Helsinn Healthcare's product portfolio include Aloxi, Gelclair, Akynzeo in the area of cancer; Nimesulide, in the area of pain and inflammation and KleanPrep a...

ImmusanT Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryImmusanT Inc ImmusanT is a biotechnology company that discovers and develops therapies for celiac disease. The company's pipeline products portfolio includes Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT s pipeline products are also used for the treatment of diabetes, thyroid autoimmunity, autoimmune liver disea...

Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 2022 Prices from USD $5900

The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed a...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryH. Lee Moffitt Cancer Center Research Institute Inc Moffitt is a notforprofit cancer treatment and research institution that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional...

US Thyroid Cancer Market: Trends and Opportunities 2015 2019 Prices from USD $800

Scope of the ReportThe report titled US Thyroid Cancer Market: Trends and Opportunities 20152019 provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone ...

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Transitional Cell Cancer Urothelial Cell Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Transitional ...

Prostate Cancer US Drug Forecast and Market Analysis to 2023 Prices from USD $4995

Prostate Cancer US Drug Forecast and Market Analysis to 2023SummaryProstate cancer is the second most common cancer in men worldwide, after skin cancer. It accounts for 15% of all the cancers diagnosed in men, and thus represents a huge burden on healthcare systems. While patients diagnosed with earlystage, localized prostate cancer can be cured, patients who are diagnosed with or progress to cas...

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Nonseminomatous Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Nonseminomatous Testicular Cancer. Report includes an o...

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Ovarian Cancer. Report includes an overview of trial numbers and the...

Salivary Gland Cancer Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Salivary Gland Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Salivary Gland Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Salivary Gland Cancer. Report includes an overview of trial numbers and their average enrol...

HER2Negative Breast Cancer US Drug Forecast and Market Analysis to 2023 Prices from USD $4995

HER2Negative Breast Cancer US Drug Forecast and Market Analysis to 2023SummaryBreast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2negative breast cancer market, with coverage of multiple settings; neoadjuvant, adjuvan...

SmallCell Lung Cancer Global Clinical Trials Review, H1, 2016 Prices from USD $2500

SmallCell Lung Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, SmallCell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of SmallCell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on SmallCell Lung Cancer. Report includes an overview of trial numbers and their average enrol...

Cancer AnorexiaCachexia Syndrome Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Cancer AnorexiaCachexia Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Cancer AnorexiaCachexia Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Cancer AnorexiaCachexia Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer AnorexiaCachexia Syndrome. Report includes an overv...

Quick Search
Advertisement
 

review and buy Gastroenterology market research data and corporate reports here